|
|
|
|
| LEADER |
01000cam a2200265 4500 |
| 001 |
744909147 |
| 003 |
DE-627 |
| 005 |
20220714130550.0 |
| 007 |
tu |
| 008 |
130502s2013 xxu||||| 00| ||eng c |
| 010 |
|
|
|a 2013932398
|
| 020 |
|
|
|a 1627033386
|9 1-62703-338-6
|
| 020 |
|
|
|a 9781627033381
|9 978-1-62703-338-1
|
| 035 |
|
|
|a (DE-627)744909147
|
| 035 |
|
|
|a (DE-599)GBV744909147
|
| 035 |
|
|
|a (OCoLC)821217442
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a eng
|
| 044 |
|
|
|c XD-US
|
| 050 |
|
0 |
|a QP93.5
|
| 082 |
0 |
|
|a 616.1/57
|2 23
|
| 084 |
|
|
|a 44.86
|2 bkl
|
| 245 |
1 |
0 |
|a Haemostasis
|b methods and protocols
|c edited by Paul Monagle
|
| 264 |
|
1 |
|a New York [u.a.]
|b Humana Pr.
|c c2013
|
| 300 |
|
|
|a XII, 431 S.
|b ill
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a ohne Hilfsmittel zu benutzen
|b n
|2 rdamedia
|
| 338 |
|
|
|a Band
|b nc
|2 rdacarrier
|
| 490 |
1 |
|
|a Methods in Molecular Biology
|v 992
|
| 490 |
0 |
|
|a Springer protocls
|
| 500 |
|
|
|a Includes bibliographical references and index
|
| 505 |
8 |
0 |
|t Coagulation system in humans
|r Anthony K.C. Chan and Nethnapha Paredes
|
| 505 |
8 |
0 |
|t Coagulation system in humans
|r Anthony K.C. Chan and Nethnapha Paredes
|
| 505 |
8 |
0 |
|t Platelet physiology
|r Matthew D. Linden
|
| 505 |
8 |
0 |
|t Role of the vessel wall
|r Nethnapha Paredes and Anthony K.C. Chan
|
| 505 |
8 |
0 |
|t Specimen requirements for the haemostasis laboratory
|r Linda J. Stang and Lesley G. Mitchell
|
| 505 |
8 |
0 |
|t Methods of coagulation
|r Gemma Crighton
|
| 505 |
8 |
0 |
|t Reference ranges of coagulation tests
|r Oliver Speer ... [et al.]
|
| 505 |
8 |
0 |
|t Lupus anticoagulant testing
|r Karen Moffat, Anne Raby, and Mark Crowther
|
| 505 |
8 |
0 |
|t Activated partial thromboplastin time
|r Vera Ignjatovic
|
| 505 |
8 |
0 |
|t Prothrombin time/international normalized ratio
|r Vera Ignjatovic
|
| 505 |
8 |
0 |
|t Thrombin clotting time
|r Vera Ignjatovic
|
| 505 |
8 |
0 |
|t Thrombin generation
|r Leslie R. Berry and Anthony K.C. Chan
|
| 505 |
8 |
0 |
|t Activated clotting time (ACT)
|r Stephen Horton and Simon Augustin
|
| 505 |
8 |
0 |
|t Factor XIII assays
|r Stephen Opat ... [et al.]
|
| 505 |
8 |
0 |
|t Fibrinogen
|r Linda J. Stang and Lesley G. Mitchell
|
| 505 |
8 |
0 |
|t Platelet counting
|r Sylvain Salignac ... [et al.]
|
| 505 |
8 |
0 |
|t Platelet morphology analysis
|r Véronique Latger-Cannard ... [et al.]
|
| 505 |
8 |
0 |
|t Light transmission aggregometry
|r Juan Pablo Frontroth
|
| 505 |
8 |
0 |
|t Platelet flow cytometry
|r Matthew D. Linden
|
| 505 |
8 |
0 |
|t Anti-factor Xa (Anti-Xa) assay
|r Fiona Newall
|
| 505 |
8 |
0 |
|t Reptilase time (RT)
|r Hratsch Karapetian
|
| 505 |
8 |
0 |
|t Protamine titration
|r Fiona Newall
|
| 505 |
8 |
0 |
|t Laboratory methods for the assay of tissue factor pathway inhibitor in human plasma
|r Robyn Summerhayes
|
| 505 |
8 |
0 |
|t Heparin-induced thrombocytopenia
|r Andreas Greinacher, Birgitt Fürll, and Sixten Selleng
|
| 505 |
8 |
0 |
|t Nijmegen-Bethesda assay to measure factor VIII inhibitors
|r Elizabeth Duncan, Margaret Collecutt, and Alison Street
|
| 505 |
8 |
0 |
|t Kaolin clotting time
|r Kottayam Radhakrishnan
|
| 505 |
8 |
0 |
|t Dilute Russell's viper venom time
|r Kottayam Radhakrishnan
|
| 505 |
8 |
0 |
|t Platelet neutralization test
|r Kottayam Radhakrishnan
|
| 505 |
8 |
0 |
|t Antithrombin
|r Mirta Hepner and Vasiliki Karlaftis
|
| 505 |
8 |
0 |
|t Protein C
|r Mirta Hepner and Vasiliki Karlaftis
|
| 505 |
8 |
0 |
|t Protein S
|r Mirta Hepner and Vasiliki Karlaftis
|
| 505 |
8 |
0 |
|t Testing for hyperhomocysteinemia in subjects with a history of thromboembolic events using HPLC technique
|r Jonas Denecke
|
| 505 |
8 |
0 |
|t Anticardiolipin antibody and anti-beta 2 glycoprotein I antibody assays
|r Anne Raby, Karen Moffat, and Mark Crowther
|
| 505 |
8 |
0 |
|t Testing for apolipoprotein(a) phenotype using isoelectric focusing and immunoblotting technique
|r Claus Langer, Bertram Tambyrayah, and Ulrike Nowak-Göttl
|
| 505 |
8 |
0 |
|t D-dimer and fibrinogen/fibrin degradation products
|r Linda J. Stang.
|
| 505 |
8 |
0 |
|t Platelet physiology
|r Matthew D. Linden
|
| 505 |
8 |
0 |
|t Role of the vessel wall
|r Nethnapha Paredes and Anthony K.C. Chan
|
| 505 |
8 |
0 |
|t Specimen requirements for the haemostasis laboratory
|r Linda J. Stang and Lesley G. Mitchell
|
| 505 |
8 |
0 |
|t Methods of coagulation
|r Gemma Crighton
|
| 505 |
8 |
0 |
|t Reference ranges of coagulation tests
|r Oliver Speer ... [et al.]
|
| 505 |
8 |
0 |
|t Lupus anticoagulant testing
|r Karen Moffat, Anne Raby, and Mark Crowther
|
| 505 |
8 |
0 |
|t Activated partial thromboplastin time
|r Vera Ignjatovic
|
| 505 |
8 |
0 |
|t Prothrombin time/international normalized ratio
|r Vera Ignjatovic
|
| 505 |
8 |
0 |
|t Thrombin clotting time
|r Vera Ignjatovic
|
| 505 |
8 |
0 |
|t Thrombin generation
|r Leslie R. Berry and Anthony K.C. Chan
|
| 505 |
8 |
0 |
|t Activated clotting time (ACT)
|r Stephen Horton and Simon Augustin
|
| 505 |
8 |
0 |
|t Factor XIII assays
|r Stephen Opat ... [et al.]
|
| 505 |
8 |
0 |
|t Fibrinogen
|r Linda J. Stang and Lesley G. Mitchell
|
| 505 |
8 |
0 |
|t Platelet counting
|r Sylvain Salignac ... [et al.]
|
| 505 |
8 |
0 |
|t Platelet morphology analysis
|r Veronique Latger-Cannard ... [et al.]
|
| 505 |
8 |
0 |
|t Light transmission aggregometry
|r Juan Pablo Frontroth
|
| 505 |
8 |
0 |
|t Platelet flow cytometry
|r Matthew D. Linden
|
| 505 |
8 |
0 |
|t Anti-factor Xa (Anti-Xa) assay
|r Fiona Newall
|
| 505 |
8 |
0 |
|t Reptilase time (RT)
|r Hratsch Karapetian
|
| 505 |
8 |
0 |
|t Protamine titration
|r Fiona Newall
|
| 505 |
8 |
0 |
|t Laboratory methods for the assay of tissue factor pathway inhibitor in human plasma
|r Robyn Summerhayes
|
| 505 |
8 |
0 |
|t Heparin-induced thrombocytopenia
|r Andreas Greinacher, Birgitt Furll, and Sixten Selleng
|
| 505 |
8 |
0 |
|t Nijmegen-bethesda assay to measure factor VIII inhibitors
|r Elizabeth Duncan, Margaret Collecutt, and Alison Street
|
| 505 |
8 |
0 |
|t Kaolin Clotting Time
|r Kottayam Radhakrishnan
|
| 505 |
8 |
0 |
|t Dilute Russell's Viper Venom Time
|r Kottayam Radhakrishnan
|
| 505 |
8 |
0 |
|t Platelet neutralization test
|r Kottayam Radhakrishnan
|
| 505 |
8 |
0 |
|t Antithrombin
|r Mirta Hepner and Vasiliki Karlaftis
|
| 505 |
8 |
0 |
|t Protein C
|r Mirta Hepner and Vasiliki Karlaftis
|
| 505 |
8 |
0 |
|t Protein S
|r Mirta Hepner and Vasiliki Karlaftis
|
| 505 |
8 |
0 |
|t Testing for hyperhomocysteinemia in subjects with a history of thromboembolic events using HPLC technique
|r Jonas Denecke
|
| 505 |
8 |
0 |
|t Anticardiolipin antibody and anti-beta 2 glycoprotein I Antibody Assays
|r Anne Raby, Karen Moffat, and Mark Crowther
|
| 505 |
8 |
0 |
|t Testing for apolipoprotein(a) phenotype using isoelectric focusing and immunoblotting technique
|r Claus Langer, Bertram Tambyrayah, and Ulrike Nowak-Gottl
|
| 505 |
8 |
0 |
|t D-dimer and fibrinogen/fibrin degradation products
|r Linda J. Stang.
|
| 650 |
|
0 |
|a Hemostasis
|
| 650 |
|
2 |
|a Hemostasis
|v Laboratory Manuals
|
| 650 |
|
2 |
|a Blood Physiological Phenomena
|v Laboratory Manuals
|
| 650 |
|
2 |
|a Blood Chemical Analysis
|x methods
|v Laboratory Manuals
|
| 689 |
0 |
0 |
|D s
|0 (DE-588)4069555-4
|0 (DE-627)106103253
|0 (DE-576)20917708X
|a Blutstillung
|2 gnd
|
| 689 |
0 |
|
|5 (DE-627)
|
| 700 |
1 |
|
|a Monagle, Paul T.
|e herausgeberin
|0 (DE-588)1089424787
|0 (DE-627)853243077
|0 (DE-576)459618490
|4 edt
|
| 776 |
1 |
|
|z 9781627033398
|c eBook
|
| 830 |
|
0 |
|a Methods in molecular biology
|v 992
|9 992
|w (DE-627)131029002
|w (DE-576)010864504
|w (DE-600)1095346-2
|x 1064-3745
|7 ns
|
| 856 |
4 |
2 |
|u https://www.springer.com/de/book/9781627033381
|x Verlag
|y Inhaltsverzeichnis und Leseprobe
|
| 912 |
|
|
|a GBV_ILN_55
|
| 912 |
|
|
|a ISIL_DE-Goe116
|
| 912 |
|
|
|a SYSFLAG_1
|
| 912 |
|
|
|a GBV_KXP
|
| 912 |
|
|
|a GBV_ILN_70
|
| 912 |
|
|
|a ISIL_DE-89
|
| 912 |
|
|
|a GBV_ILN_290
|
| 912 |
|
|
|a ISIL_DE-D267
|
| 936 |
b |
k |
|a 44.86
|j Hämatologie
|0 (DE-627)106409409
|
| 951 |
|
|
|a BO
|
| 953 |
|
|
|2 045F
|a 616.1/57
|
| 980 |
|
|
|2 55
|1 01
|x 3055
|b 1383508844
|c 00
|f --%%--
|d E 4/07
|e --%%--
|j --%%--
|y z
|z 02-05-13
|
| 980 |
|
|
|2 70
|1 01
|x 0089
|b 3729184326
|c 00
|f Haus2
|d RA 8825(992)
|e u
|j --%%--
|y z
|z 01-09-20
|
| 980 |
|
|
|2 290
|1 01
|x 3290
|b 1389544974
|c 00
|f --%%--
|d MMB 992
|e c
|j --%%--
|y k
|z 07-05-13
|
| 984 |
|
|
|2 70
|1 01
|x 0089
|a 89$142411264
|
| 984 |
|
|
|2 290
|1 01
|x 3290
|a D267$9007199
|
| 985 |
|
|
|2 290
|1 01
|x 3290
|a Z 13435
|
